Sandoz, the generic arm of Novartis (NVS), recently announced that it has received marketing authorization for AirFluSal Forspiro in Denmark. AirFluSal Forspiro is a new inhaler for patients suffering ...
LONDON (Alliance News) - LONDON (Alliance News) - Vectura Group PLC Monday said partner Sandoz has received marketing authorisation from Norwegian authorities for its asthma inhaler AirFluSal Forspiro ...
Chippenham, UK - 10 February 2014: Vectura Group plc (LSE: VEC; "Vectura" or "the Company") confirms that our partner, Sandoz, has received Norwegian marketing authorisation for AirFluSal® Forspiro® ...
Technologycategory Northvolt crisis may be make or break for Europe's EV battery ambitions 6:20 PM UTC Marketscategory Mexico's cooling inflation and economy growth drive expectations of further rate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results